Achieve Life Sciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-2.83-7.863.820.81
Price/Sales ratio
1.550.670.200.10
Earnings per Share (EPS)
$-0.95$-0.34$0.70$3.32

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.57-1.88-0.74-0.60-0.33-0.27-1.50-1.92-0.61-2.73-1.71-0.27
Price/Sales ratio
1.521.742.95N/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
1.210.840.780.810.260.240.592.253.12-56.4163.040.26
Price/Cash Flow ratio
-2.39-3.47-0.50-0.70-0.39-0.28-1.63-2.14-0.69-3.33-2.08-0.28
Price/Free Cash Flow ratio
-2.38-3.34-0.50-0.70-0.39-0.28-1.63-2.14-0.69-3.33-2.08-0.28
Price/Earnings Growth ratio
0.040.03-0.160.000.000.000.010.070.250.04-0.060.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-108.66%-103.26%-418.64%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-96.76%-92.51%-397.64%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-96.76%-92.51%-397.64%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
13.31%11.61%5.28%22.37%0.99%1.54%0.46%0.75%1.12%N/AN/A1.54%
Return on Assets
-46.61%-28.86%-73.27%-106.98%-66.47%-76.57%-36.38%-69.24%-139.71%-153.91%-161.31%-76.57%
Return On Equity
-77.04%-44.87%-106.13%-134.31%-80.28%-89.42%-39.32%-117.33%-504.33%2059.04%-240.36%-89.42%
Return on Capital Employed
-86.47%-49.94%-111.44%-84.17%-81.02%-90.76%-39.47%-77.02%-166.91%1889.73%-220.46%-90.76%
Liquidity Ratios
Current Ratio
2.502.773.182.934.756.0412.59N/AN/AN/A3.036.04
Quick Ratio
2.482.783.212.824.766.0612.599.804.940.812.656.06
Cash ratio
1.251.661.802.622.905.8012.219.454.480.742.635.80
Days of Sales Outstanding
77.922.5136.77N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/A287.34-64.71-11.49N/AN/A-3.85KN/AN/A-64.71
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/A275.69186.381.23K475.211.22K2.56K989.34N/A1.23K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.000.000.030.000.000.010.000.310.530.860.950.00
Debt Equity Ratio
0.000.000.040.000.000.020.000.531.93-11.5021.720.00
Long-term Debt to Capitalization
N/A0.00N/AN/A0.000.00N/A0.34N/AN/A0.930.00
Total Debt to Capitalization
0.000.000.040.000.000.010.000.340.651.090.930.00
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-29.76N/A
Cash Flow to Debt Ratio
-73.33-86.67-35.80-337.29-461.86-42.03-146.45-1.96-2.33-1.46-2.00-461.86
Company Equity Multiplier
1.651.551.441.251.201.161.081.693.60-13.3722.721.20
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.63-0.50-5.86N/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.041.0011.001.001.001.0011.0011.00
Cash Flow Coverage Ratio
-73.33-86.67-35.80-337.29-461.86-42.03-146.45-1.96-2.33-1.46-2.00-461.86
Short Term Coverage Ratio
-73.33N/A-35.80-337.29-965.72-74.95-146.45-426.66-2.33-1.46-1.37K-74.95
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A